✦ LIBER ✦

M1143 Benefits of Dosage Adjustment with Adalimumab in Crohn's Disease: An Analysis of the CHARM Trial

✍ Scribed by Sandborn, William J.; Colombel, Jean-Frédéric; Rutgeerts, Paul; Pollack, Paul F.; Chao, Jingdong; Mulani, Parvez

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P079 BENEFITS OF DOSAGE ADJUSTMENT WITH

✍ W.J. Sandborn; J.F. Colombel; P. Rutgeerts; P.F. Pollack; J. Chao; P. Mulani 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 71 KB

Adalimumab for Maintenance of Clinical R

✍ Jean–Frédéric Colombel; William J. Sandborn; Paul Rutgeerts; Robert Enns; Stephe 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 712 KB

Effect of adalimumab on clinical laborat

✍ David T. Rubin; Parvez Mulani; Jingdong Chao; Paul F. Pollack; Arielle G. Bensim 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 788 KB

P114 ADALIMUMAB SAFETY IN CROHN'S DISEAS

✍ J.F. Colombel; W.J. Sandborn; W. Reinisch; S.B. Hanauer; P. Rutgeerts; J. Li; P. 📂 Article 📅 2007 🏛 Oxford University Press ⚖ 60 KB

Adalimumab Induces and Maintains Clinica

✍ J. Colombel; W.J. Sandborn; P. Rutgeerts; R. Enns; S.B. Hanauer; P. Remo; S. Sch 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 46 KB

P243 Subgroup analysis of the placebo-co

✍ S. Schreiber; W. Reinisch; J.-F. Colombel; W. Sandborn; A. Robinson; B. Huang; K 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 49 KB